Vestcor Inc’s Castle Biosciences CSTL Stock Holding History

Vestcor Inc’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-318	Closed	-$16K	–	990
2020 Q3	$16K	Hold	318	–	–	﹤0.01%	894
2020 Q2	$12K	Buy	+318	New	+$10.9K	﹤0.01%	836

Other funds holding CSTL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vestcor Inc's CSTL Position: Q4 2020 in Review

Vestcor Inc sold out of Castle Biosciences (CSTL) in Q4 2020, closing a stake of 318 shares — an estimated $16K sold.

Vestcor Inc first reported a position in CSTL in Q2 2020 and held it in 2 quarters. The position peaked at $16K in Q3 2020. 163 funds tracked by Wall St. Rank hold CSTL as of Q4 2020.

Vestcor Inc reported no remaining Castle Biosciences position as of Q4 2020 after selling out during the quarter.
Vestcor Inc sold 318 Castle Biosciences shares in Q4 2020, an estimated $16K.
Vestcor Inc first reported a position in Castle Biosciences in Q2 2020 and held it in 2 quarters.
Vestcor Inc's Castle Biosciences position peaked at $16K in Q3 2020.
163 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2020.

Based on Vestcor Inc's 13F filing for Q4 2020, filed 16 Feb 2021.